 Maravai LifeSciences Holdings, Inc. NASDAQ:MRVI Q3 2022 Results Conference Call November 2, 2022 5:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull - Interim Chief Executive Officer Kevin Herde - Chief Financial Officer Conference Call Participants Tejas Savant - Morgan Stanley John Sourbeer - UBS Paul Knight - KeyBanc Madeline Mollman - William Blair Michael Ryskin - Bank of America Dan Arias - Stifel Dan Leonard - Credit Suisse Brandon Couillard - Jefferies Operator Greetings, and welcome to Maravai LifeSciences Third Quarter 2022 Earnings Conference Call. Operator Instructions As a reminder, this conference is being recorded. 